Martin Axon is Principal Occupational Hygienist for SafeBridge Europe and is a Chartered Fellow of the Faculty of Occupational Hygiene; he has degrees in Industrial Chemistry and Environmental Pollution Science. He has over 25 years of experience working in the pharmaceutical industry in the UK and internationally, where, as an occupational hygienist for primary and secondary sites, he provided support for potent pharmaceutical product manufacture. During mid-career he was Course Director for a postgraduate programme in Occupational Hygiene, Health and Safety, at London South Bank University.
Martin joined SafeBridge in 2005. His current role includes managing SafeBridge’s services in Europe and advising clients on the safe handling of potent pharmaceutical compounds in a range of environments, from laboratory scale through to secondary manufacture.
The pharmaceutical sector uniquely carries out extensive testing of their products on human subjects. This testing provides data that allows toxicologists to develop safe limits for occupational exposure. However, ultra-high potent pharmaceuticals, with exposure limits below 10 ng/m3 provide challenges by pushing the containment technology and the verification of this technology to the limits of what is achievable.View Details